Stop what you are doing and take a moment to read a science paper on artificial intelligence https://t.co/1MYi80ByQI
RT @RealMargaretta: Tweet a link to this recent Nature paper with hashtag #DeepKnowledge and we'll tweet you a link to a free report on AI…
#mitomouse @InSilicoMeds, @senstweet, @LifespanIO
RT @LifespanIO: Insilico are giving $1 to MitoMouse campaign for every tweet of the link to their new paper with the hashtag #mitomouse Ma…
New molecules "Dreamed" by Artificial Intelligence in 46 days. Read the Nature article and learn about this new technology: https://t.co/56RZHvNBVL
Artificial intelligence is rapidly advancing. It can now design novel druglike molecules in 46 days instead of years. https://t.co/bixwO3PWD0
RT @RealMargaretta: Tweet a link to this recent Nature paper with hashtag #DeepKnowledge and we'll tweet you a link to a free report on AI…
RT @TechOptimals: Imaginative artificial intelligence now achieved superhuman performance in drug discovery explained in this paper by Insi…
RT @TechOptimals: Imaginative artificial intelligence now achieved superhuman performance in drug discovery explained in this paper by Insi…
RT @TechOptimals: Imaginative artificial intelligence now achieved superhuman performance in drug discovery explained in this paper by Insi…
RT @TechOptimals: Imaginative artificial intelligence now achieved superhuman performance in drug discovery explained in this paper by Insi…
RT @TechOptimals: Imaginative artificial intelligence now achieved superhuman performance in drug discovery explained in this paper by Insi…
RT @TechOptimals: Imaginative artificial intelligence now achieved superhuman performance in drug discovery explained in this paper by Insi…
RT @TechOptimals: Imaginative artificial intelligence now achieved superhuman performance in drug discovery explained in this paper by Insi…
RT @LifespanIO: Insilico are giving $1 to MitoMouse campaign for every tweet of the link to their new paper with the hashtag #mitomouse Ma…
RT @LifespanIO: Insilico are giving $1 to MitoMouse campaign for every tweet of the link to their new paper with the hashtag #mitomouse Ma…
Insilico are giving $1 to MitoMouse campaign for every tweet of the link to their new paper with the hashtag #mitomouse Make sure to mention @InSilicoMeds, @senstweet, @LifespanIO in your tweet. https://t.co/Oh1Drrtmlw
Tweet a link to this recent Nature paper with hashtag #DeepKnowledge and we'll tweet you a link to a free report on AI in drug discovery https://t.co/eBxTxZhzBf #ArtificialIntelligence #innovation #VentureCapital @theoneamit @HCITExpert @nxpatel @IraneusOg
RT @nxpatel: @suchisaria GANs for drug design (proof-of-concept). https://t.co/7LbqYVgm3b Classification from dx only-labeled images (addr…
RT @IraneusOgu: African countries should now consider national strategies to use AI and build new industries especially in healthcare. And…
@suchisaria GANs for drug design (proof-of-concept). https://t.co/7LbqYVgm3b Classification from dx only-labeled images (addresses challenge of poor data labeling in path): https://t.co/6rcogbgyor Predicting MSI from slides (cheaper than seq to assign ta
Human genetics innovation. #biotech #medicine #science @InSilicoMeds https://t.co/eLC3FoF0sO
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | #deeplearning #drugdesign #GENTRL https://t.co/gvLUh9JHe5
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
@InSilicoMeds will be at #NeurIPS2019 This year. The new math that can be applied to generative chemistry like this will be presented. https://t.co/cyafxr1ZK5 https://t.co/wuUvvy76f3
RT @aubreydegrey: Insilico publishes GENTRL. They use GAN-RL technology to collaborate with the leading longevity companies including Juven…
RT @aubreydegrey: Insilico publishes GENTRL. They use GAN-RL technology to collaborate with the leading longevity companies including Juven…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Impressive progress using AI for drug discovery from Insilico Medicine https://t.co/fTXlRgqrba
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @PRNhealth: Following the popular NB publication https://t.co/pUJJaxetQw Insilico Medicine & CTFH announce a $200 million drug discovery…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @InSilicoMeds: Experimental validation of molecules "imagined" by next-gen artificial intelligence https://t.co/GORcuUlDye #ArtificialI…
RT @PRNhealth: Following the popular NB publication https://t.co/pUJJaxetQw Insilico Medicine & CTFH announce a $200 million drug discovery…
RT @GeorgeSeif94: Excellent application of #DeepLearning. Healthcare is a massive field where AI can be applied and will most definitely ha…
Following the popular NB publication https://t.co/pUJJaxetQw Insilico Medicine & CTFH announce a $200 million drug discovery partnership using AI https://t.co/dUMSQu8mnN https://t.co/aiVL4YqCW7
@InSilicoMeds recent Nature Biotech publication + Deep Genomics Topic: Early evidence of AI’s transformative potential in pre-clinical drug discovery. September was a big month for the #AI for drug discovery community. https://t.co/bNYAr9PRGK
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/4CspOL7NqN
sabían que este año se usó una inteligencia artificial para crear medicamentos, la cual después de solo 21 días, en setiembre, creó 6 de los cuales 1 mostró funcionar? https://t.co/PregYj0sY4 https://t.co/zDWslZ548e
RT @FuturistAvenue: Discovering a new drug can take decades, billions of dollars, and untold man hours from some of the smartest people on…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
Discovering a new drug can take decades, billions of dollars, and untold man hours from some of the smartest people on the planet. Now a startup says it’s taken a significant step towards speeding the process up using AI 💡 ⚛ https://t.co/grtHLvUDN2 📰 htt
AI in Drug Discovery #nature #naturebiotech #ArtificialIntelligence #DeepLearning https://t.co/BJXZmCDqcy
RT @fmkz___: 元論文これで、これの煽り日本語記事どこかが出してたっけ?biotodayか? https://t.co/BIE7PbttaJ
元論文これで、これの煽り日本語記事どこかが出してたっけ?biotodayか? https://t.co/BIE7PbttaJ
RT @AgingEconomist: To all my Spanish-speaking friends - a video on the future of drug discovery https://t.co/IYFM4uFn3Q
When we have lots of information, applying generative models to graphs of structural data can design drugs in silico (https://t.co/7LbqYVgm3b). While we don't publicly have that for most compounds, I'm sure Novartis has a bucket of private experimental dat
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/0J5dqoCJuy
RT @biogerontology: Supercool coverage of AI-powered drug discovery by Mexican-Canadian @A_Aspuru_Guzik in Spanish by @CdeCiencia . https:…
Supercool coverage of AI-powered drug discovery by Mexican-Canadian @A_Aspuru_Guzik in Spanish by @CdeCiencia . https://t.co/DUYDa1DOAx https://t.co/cyafxr1ZK5
RT @biogerontology: Very often we overlook synthetic chemists. But they are often doing most of the hard work. Big hand to synthetic chemis…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/zTvNVHBzYJ #deeplearning #health #TechNews
RT @biogerontology: Very often we overlook synthetic chemists. But they are often doing most of the hard work. Big hand to synthetic chemis…
RT @biogerontology: Very often we overlook synthetic chemists. But they are often doing most of the hard work. Big hand to synthetic chemis…
Very often we overlook synthetic chemists. But they are often doing most of the hard work. Big hand to synthetic chemistry geniuses who work at lightning speeds. 🙏🤝💪 https://t.co/cyafxr1ZK5 https://t.co/q9fPNd3L4W
New Scientific Paper: "Deep learning enables rapid identification of potent DDR1 kinase inhibitors" https://t.co/UafLlPRXJH cc @biogerontology @AIBioSummit
RT @pelexus: '딥러닝으로 46일만에 신약 후보 물질을 디자인한다' 최근 nature biotech에 실린 논문 https://t.co/cQjHBRGADz 에 대해서 블로그에 정리해보았습니다. https://t.co/pJeoqeVV5S
Unique and potent drug compounds for the treatment of fibrosis disease imagined and discovered using artificial intelligence 🩺 📰 News Story: https://t.co/4rLT6fVtEW 💡 Nature Biotech: https://t.co/grtHLvUDN2 #biotech 🏷 #AI 🏷 #pharmacology
RT @biogerontology: We will soon announce the extension of the model used in our recent paper and are now looking for a fun way to represen…
We will soon announce the extension of the model used in our recent paper and are now looking for a fun way to represent the pipeline with multiple generative systems. Inspired by the Ghost in a Shell. What do you think about this one? #meditativeAI https
RT @biogerontology: Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generati…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @biogerontology: Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generati…
RT @biogerontology: Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generati…
Imagine getting diagnosed and prescribed the cure, for pancreatic cancer or Alzheimers, all in the same day.
RT @pelexus: '딥러닝으로 46일만에 신약 후보 물질을 디자인한다' 최근 nature biotech에 실린 논문 https://t.co/cQjHBRGADz 에 대해서 블로그에 정리해보았습니다. https://t.co/pJeoqeVV5S
'딥러닝으로 46일만에 신약 후보 물질을 디자인한다' 최근 nature biotech에 실린 논문 https://t.co/cQjHBRGADz 에 대해서 블로그에 정리해보았습니다. https://t.co/pJeoqeVV5S
@A_Aspuru_Guzik @meaganoakley Twitterista? Hello! Let's tweet this: 🤖 https://t.co/cyafxr1ZK5
RT @biogerontology: Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generati…
RT @biogerontology: Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generati…
It is very cool!
RT @biogerontology: Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generati…
RT @biogerontology: Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generati…
Very few people in AI and drug discovery industry realize how many times you need to fail in order to get your generative molecules to consistently produce good molecules. Synthesize, test, learn, repeat. I tried to visualize it as Molecular Sparta... http
AI is promising tool for drug discovery #ArtificialIntelligence #Naturebiotech #Nature # Deeplearning @biogerontology https://t.co/iobNXmTrZX
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @kaifulee: Fully agree, @EricTopol. AI drug discovery in 46 days! Very encouraging to see the AI empowered breakthrough by our newly add…
Artificial Intelligence In Drug Discovery #insilico#insilicomedicine#ai#DDR1, #Nature#insilicomeds, published in #NatureBiotech, #InsilicoAI @InSilicoMeds @biogerontology https://t.co/eIsNYu51Fn
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKlT3yb #DeepLearning
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKlT3yb #DeepLearning
RT @AgingEconomist: It still resonates! https://t.co/VtZ0q9BoRh
Wow, Lead compound identification in 21 days by AI #insilico#insilicomedicine#ai#DDR1, #Nature#insilicomeds, published in #ArtificialInteligence #MachineLearning #drugdiscovery #NatureBiotech, @InSilicoMeds https://t.co/uQ5JGfyYG7
RT @nresearchnews: A @NatureBiotech paper describes a machine learning model that allows for the identification of new small-molecule kinas…
RT @romanyam: Brilliant work published in @NatureBiotec by @biogerontology et al. Highly recommended. https://t.co/h45k4LT8fX
Artificial intelligence into drug discovery #ArtificialIntelligence #drugdiscovery #NatureBiotech https://t.co/FWjdEuMr3y
RT @AgingEconomist: It still resonates! https://t.co/VtZ0q9BoRh